Efavirenz detectable in plasma 8 weeks after stopping therapy and subsequent development of non-nucleoside reverse transcriptase inhibitor-associated resistance

AIDS. 2005 Oct 14;19(15):1716-7. doi: 10.1097/01.aids.0000186828.99032.60.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Alkynes
  • Anti-HIV Agents / blood*
  • Benzoxazines
  • Cyclopropanes
  • Drug Resistance, Viral
  • Female
  • HIV Infections / blood*
  • HIV-1 / isolation & purification*
  • Humans
  • Oxazines / blood*
  • Reverse Transcriptase Inhibitors / blood

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • efavirenz